› Forums › General Melanoma Community › Avelumab clinical trial vs opdivo/ ketruda
- This topic has 36 replies, 6 voices, and was last updated 10 years ago by
Marianne quinn.
- Post
-
- August 18, 2015 at 1:55 am
Its possible my husband could start a clinical trial for Avelumab. He has a choice between that and Opdivo or Keytruda.He was diagnosed in February with stage 3b. He had the main tumor, a satellite, two pre melanomas and four lymph nodes removed in the first surgery. 3 of the 4 nodes were positive so he had his axillary nodes removed. Then had radiation and yervoy. The last scan revealed a 1 cm spot on his liver. Now its time to decide the next step.
There is a clinical trial for Avelumab. A drug that i can find very little about. I tend to gather as much information as possible from anywhere i can, so not being able to find information is unsettling for me. Still, its a new drug and I have only been in the cancer game for a few months.
Or he could go with Opdivo or Keytruda. Has anyone faced this dilemma? Or something close to it?? Or perhaps, have any information that I dont on this new drug for treating Melanoma?
Thank you,
- Replies
-
-
- August 18, 2015 at 2:39 am
Rebekah, I am a Stage IV patient who took Nivo (Opdivo) for 2 1/2 years starting in 2010 and did well….remaining NED so far. Opdivo and Keytruda are very similar anti-PD1 products. Avelumab is an anti-PDL1 product..of which there are several. Here is a link to some specific info from ASCO 2015: http://meetinglibrary.asco.org/content/147989-156
Here is a link to some info regarding other anti-PDL1 products: http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2014/03/anti-pdl1-for-melanoma-phase-1-trial-of.html
Sadly, what works for one melanoma patient doesn't always work for another…so it is hard to choose what to do. I would presume that if they are offering your husband this trial that your husband's tumor has been tested for PD-L1 expresssion and he has it…because that is super important for response here (in my opinion!). There is plenty of info on this forum and on my blog regarding the anti-PD1 products if you need more info to compare (use the search bubble on my blog if you are interested).
Hope this helps. I wish you and your husband my best. Celeste
-
- August 18, 2015 at 2:39 am
Rebekah, I am a Stage IV patient who took Nivo (Opdivo) for 2 1/2 years starting in 2010 and did well….remaining NED so far. Opdivo and Keytruda are very similar anti-PD1 products. Avelumab is an anti-PDL1 product..of which there are several. Here is a link to some specific info from ASCO 2015: http://meetinglibrary.asco.org/content/147989-156
Here is a link to some info regarding other anti-PDL1 products: http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2014/03/anti-pdl1-for-melanoma-phase-1-trial-of.html
Sadly, what works for one melanoma patient doesn't always work for another…so it is hard to choose what to do. I would presume that if they are offering your husband this trial that your husband's tumor has been tested for PD-L1 expresssion and he has it…because that is super important for response here (in my opinion!). There is plenty of info on this forum and on my blog regarding the anti-PD1 products if you need more info to compare (use the search bubble on my blog if you are interested).
Hope this helps. I wish you and your husband my best. Celeste
-
- August 18, 2015 at 3:30 am
I appreciate your response sooo much. He has not been tested for the PD-L1 Expression. I havent even heard of that until just now. He is getting a biopsy scheduled sometime this week. (He just had his appointment today.) I will look into it. I will look at the links you posted. And i appreciate the help. Im happy that you’re NED. -
- August 18, 2015 at 3:30 am
I appreciate your response sooo much. He has not been tested for the PD-L1 Expression. I havent even heard of that until just now. He is getting a biopsy scheduled sometime this week. (He just had his appointment today.) I will look into it. I will look at the links you posted. And i appreciate the help. Im happy that you’re NED. -
- August 18, 2015 at 4:26 am
Demand to see an interventional radiologis! My husband had the same thing. He had a small liver lesion after induction with ipi. We were devastated. Fortunately, his oncologist sent him to have ablated by microwave. Fairly easy procedure which was complicated by a previous abdominal surgery due to an accident. He did well and is NED for 18 months with no further treatment. There are patients who have had an "atypical" response To ipi who have done very well. Also, a recent study indicated that melanoma patients who undergo ablation do very well. Ablation can only be done on small lesions. Further. Immune therapy may not be needed now.
-
- August 18, 2015 at 4:26 am
Demand to see an interventional radiologis! My husband had the same thing. He had a small liver lesion after induction with ipi. We were devastated. Fortunately, his oncologist sent him to have ablated by microwave. Fairly easy procedure which was complicated by a previous abdominal surgery due to an accident. He did well and is NED for 18 months with no further treatment. There are patients who have had an "atypical" response To ipi who have done very well. Also, a recent study indicated that melanoma patients who undergo ablation do very well. Ablation can only be done on small lesions. Further. Immune therapy may not be needed now.
-
- August 18, 2015 at 4:26 am
Demand to see an interventional radiologis! My husband had the same thing. He had a small liver lesion after induction with ipi. We were devastated. Fortunately, his oncologist sent him to have ablated by microwave. Fairly easy procedure which was complicated by a previous abdominal surgery due to an accident. He did well and is NED for 18 months with no further treatment. There are patients who have had an "atypical" response To ipi who have done very well. Also, a recent study indicated that melanoma patients who undergo ablation do very well. Ablation can only be done on small lesions. Further. Immune therapy may not be needed now.
-
- August 18, 2015 at 3:30 am
I appreciate your response sooo much. He has not been tested for the PD-L1 Expression. I havent even heard of that until just now. He is getting a biopsy scheduled sometime this week. (He just had his appointment today.) I will look into it. I will look at the links you posted. And i appreciate the help. Im happy that you’re NED.
-
- August 18, 2015 at 2:39 am
Rebekah, I am a Stage IV patient who took Nivo (Opdivo) for 2 1/2 years starting in 2010 and did well….remaining NED so far. Opdivo and Keytruda are very similar anti-PD1 products. Avelumab is an anti-PDL1 product..of which there are several. Here is a link to some specific info from ASCO 2015: http://meetinglibrary.asco.org/content/147989-156
Here is a link to some info regarding other anti-PDL1 products: http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2014/03/anti-pdl1-for-melanoma-phase-1-trial-of.html
Sadly, what works for one melanoma patient doesn't always work for another…so it is hard to choose what to do. I would presume that if they are offering your husband this trial that your husband's tumor has been tested for PD-L1 expresssion and he has it…because that is super important for response here (in my opinion!). There is plenty of info on this forum and on my blog regarding the anti-PD1 products if you need more info to compare (use the search bubble on my blog if you are interested).
Hope this helps. I wish you and your husband my best. Celeste
-
- August 18, 2015 at 1:24 pm
Hi Specka, if I am reading this correctly, they have given you a choice between trying Avelumab a Pd-L1 antibody or a choice between either Opdivo or Keytruda which are Pd-1 antibodies. Just my opinion but something to consider is we know more about the two Pd-1 drugs at this point. They are both working for about 40% of the people who try them. We also have more mature data about what they called the tail of the survival curve, when the Pd-1 drugs work. My understand of the basic science between these drugs, is that Pd-1 targets the protein on the surface on the t-cell vs pd-L1 which targets the protein on the surface of the cancer or the ligand of Pd-1. In the article Celeste presented to you they talk about weather the tumor is expressing Pd-L1 positive or negative, this tumor examination might not be available with this study. It is nice that you have so many choices at this point. Wishing you the best!!!! Ed
-
- August 18, 2015 at 1:24 pm
Hi Specka, if I am reading this correctly, they have given you a choice between trying Avelumab a Pd-L1 antibody or a choice between either Opdivo or Keytruda which are Pd-1 antibodies. Just my opinion but something to consider is we know more about the two Pd-1 drugs at this point. They are both working for about 40% of the people who try them. We also have more mature data about what they called the tail of the survival curve, when the Pd-1 drugs work. My understand of the basic science between these drugs, is that Pd-1 targets the protein on the surface on the t-cell vs pd-L1 which targets the protein on the surface of the cancer or the ligand of Pd-1. In the article Celeste presented to you they talk about weather the tumor is expressing Pd-L1 positive or negative, this tumor examination might not be available with this study. It is nice that you have so many choices at this point. Wishing you the best!!!! Ed
-
- August 18, 2015 at 3:59 pm
I showed my husband that and I think we will request that test to be done. That may help his decision.It also seems like the avelumab will be a long term infusion done every two weeks. Until it has been decided to go off of it. Im under the impression that opdivo is shorter term. Both dont have bad side effects.
-
- August 18, 2015 at 3:59 pm
I showed my husband that and I think we will request that test to be done. That may help his decision.It also seems like the avelumab will be a long term infusion done every two weeks. Until it has been decided to go off of it. Im under the impression that opdivo is shorter term. Both dont have bad side effects.
-
- August 18, 2015 at 5:36 pm
A large phase 3 trial called checkmate 67 of opdivo (nivolumab) in combination with Ipi is still going on. I have been part of the trial and due to the fact that it is double blinded we don't know for sure which of the three arms we are on. 950 patients world wide are participating and early data was published at ASCO 2015. Celeste who wrote to you above has the links to the published work on her blog. My understanding of opdivo which is given every two weeks for 2 years is that it tends to shrink tumors when it works very quickly when compared to Ipi. I had shrinkage of my lung mets on my first sets of scans at 12 weeks which I hope means that I having been recieving Opdivo for the last year and a half. The treatment has been very easy to handle when I compare my previous Interferon experience. Many of the people in the study have what is called partial responses, where the tumors shrink and then remain stable with no new growth. Having options is always nice and by doing the Avelumab trial, you still keep open the Pd-1 option. Wishing you the best!!! Ed
-
- August 18, 2015 at 5:36 pm
A large phase 3 trial called checkmate 67 of opdivo (nivolumab) in combination with Ipi is still going on. I have been part of the trial and due to the fact that it is double blinded we don't know for sure which of the three arms we are on. 950 patients world wide are participating and early data was published at ASCO 2015. Celeste who wrote to you above has the links to the published work on her blog. My understanding of opdivo which is given every two weeks for 2 years is that it tends to shrink tumors when it works very quickly when compared to Ipi. I had shrinkage of my lung mets on my first sets of scans at 12 weeks which I hope means that I having been recieving Opdivo for the last year and a half. The treatment has been very easy to handle when I compare my previous Interferon experience. Many of the people in the study have what is called partial responses, where the tumors shrink and then remain stable with no new growth. Having options is always nice and by doing the Avelumab trial, you still keep open the Pd-1 option. Wishing you the best!!! Ed
-
- August 18, 2015 at 5:36 pm
A large phase 3 trial called checkmate 67 of opdivo (nivolumab) in combination with Ipi is still going on. I have been part of the trial and due to the fact that it is double blinded we don't know for sure which of the three arms we are on. 950 patients world wide are participating and early data was published at ASCO 2015. Celeste who wrote to you above has the links to the published work on her blog. My understanding of opdivo which is given every two weeks for 2 years is that it tends to shrink tumors when it works very quickly when compared to Ipi. I had shrinkage of my lung mets on my first sets of scans at 12 weeks which I hope means that I having been recieving Opdivo for the last year and a half. The treatment has been very easy to handle when I compare my previous Interferon experience. Many of the people in the study have what is called partial responses, where the tumors shrink and then remain stable with no new growth. Having options is always nice and by doing the Avelumab trial, you still keep open the Pd-1 option. Wishing you the best!!! Ed
-
- August 18, 2015 at 3:59 pm
I showed my husband that and I think we will request that test to be done. That may help his decision.It also seems like the avelumab will be a long term infusion done every two weeks. Until it has been decided to go off of it. Im under the impression that opdivo is shorter term. Both dont have bad side effects.
-
- August 18, 2015 at 1:24 pm
Hi Specka, if I am reading this correctly, they have given you a choice between trying Avelumab a Pd-L1 antibody or a choice between either Opdivo or Keytruda which are Pd-1 antibodies. Just my opinion but something to consider is we know more about the two Pd-1 drugs at this point. They are both working for about 40% of the people who try them. We also have more mature data about what they called the tail of the survival curve, when the Pd-1 drugs work. My understand of the basic science between these drugs, is that Pd-1 targets the protein on the surface on the t-cell vs pd-L1 which targets the protein on the surface of the cancer or the ligand of Pd-1. In the article Celeste presented to you they talk about weather the tumor is expressing Pd-L1 positive or negative, this tumor examination might not be available with this study. It is nice that you have so many choices at this point. Wishing you the best!!!! Ed
-
- August 18, 2015 at 3:16 pm
Hi Rebekah,
One other thing to consider about a clinical trial vs an approved drug is that if you start with the approved drug (Keytruda or Opdivo) that might disqualify later participation in *some* not all clinical studied involving, perhaps some, immunotherapies. whereas if you start with the study drug, you should be able to fall back on keytruda or opdivo if that were to be necessary.
I am not familiar with avelumab although I almost ended up on a study with a different anti-PDL1 drug combined witj a MEK inhibitor.
Lots to consider… hooe this helps.
-Kyle
-
- August 18, 2015 at 3:16 pm
Hi Rebekah,
One other thing to consider about a clinical trial vs an approved drug is that if you start with the approved drug (Keytruda or Opdivo) that might disqualify later participation in *some* not all clinical studied involving, perhaps some, immunotherapies. whereas if you start with the study drug, you should be able to fall back on keytruda or opdivo if that were to be necessary.
I am not familiar with avelumab although I almost ended up on a study with a different anti-PDL1 drug combined witj a MEK inhibitor.
Lots to consider… hooe this helps.
-Kyle
-
- August 18, 2015 at 3:56 pm
This is one of the dilemmas. He can start avelumab first, if it doesnt work he can go on opdivo. But he cannot start opdivo then go to avelumab.I just want him to be healthy and to live a long healthy life with his annoying wife π it almost feels like we are gambling. We could go with the doctor at MDAnderson who works in the melanoma department whom we trust and beleive in. He recommends keytruda or opdivo. Or he could go with this new clinical trial that was introduced to us by a clinical trial guru who recommends avelumab. (And if it doesnt work, go to opdivo/keytruda.)
-
- August 18, 2015 at 3:56 pm
This is one of the dilemmas. He can start avelumab first, if it doesnt work he can go on opdivo. But he cannot start opdivo then go to avelumab.I just want him to be healthy and to live a long healthy life with his annoying wife π it almost feels like we are gambling. We could go with the doctor at MDAnderson who works in the melanoma department whom we trust and beleive in. He recommends keytruda or opdivo. Or he could go with this new clinical trial that was introduced to us by a clinical trial guru who recommends avelumab. (And if it doesnt work, go to opdivo/keytruda.)
-
- August 18, 2015 at 6:25 pm
What I've decided about oncologists is that I want one who is a good odds make. Because it seems that way to me too. Although I had to mix my own judgement in too since I'm the one commiting to it. What I've heard others say here is, try to make the best choice I can based on whatever input I value, then go with that decision and try not to second guess it too much. Which I did in choosing my current treatment.
I've got somethimg like 4 or 5 choices once I'm done with my current trial, which I hope will be due to fullly completing the final planned cycle. I'm not thinking to much about those post-trial choices yet.
-
- August 18, 2015 at 9:03 pm
I would consider all of the factors. Will you have to travel for the clinical trial? What kind of time commitment will it look like? Do you get a good feeling from one doctor to another? These are all things I would consider, because when it comes down to it, no one can tell you which drug will work better, but you need to be satisfied with your decision and not have regrets or what if's.
I would definetely get it tested as celeste suggested, but just know that Keytruda and Opdivo were fast tracked through FDA approval because of the amazing response rate. Many stage 4 husbands are out there living life with their annoying wives π because of these drugs.
Good luck with whatever you choose!
-
- August 18, 2015 at 9:03 pm
I would consider all of the factors. Will you have to travel for the clinical trial? What kind of time commitment will it look like? Do you get a good feeling from one doctor to another? These are all things I would consider, because when it comes down to it, no one can tell you which drug will work better, but you need to be satisfied with your decision and not have regrets or what if's.
I would definetely get it tested as celeste suggested, but just know that Keytruda and Opdivo were fast tracked through FDA approval because of the amazing response rate. Many stage 4 husbands are out there living life with their annoying wives π because of these drugs.
Good luck with whatever you choose!
-
- August 18, 2015 at 9:03 pm
I would consider all of the factors. Will you have to travel for the clinical trial? What kind of time commitment will it look like? Do you get a good feeling from one doctor to another? These are all things I would consider, because when it comes down to it, no one can tell you which drug will work better, but you need to be satisfied with your decision and not have regrets or what if's.
I would definetely get it tested as celeste suggested, but just know that Keytruda and Opdivo were fast tracked through FDA approval because of the amazing response rate. Many stage 4 husbands are out there living life with their annoying wives π because of these drugs.
Good luck with whatever you choose!
-
- August 18, 2015 at 9:04 pm
Hi – ablation is a relatively Minot surgical procedure done by an interventional radiologist. A small incision is made and under X-ray guidance a probe is placed and microwaves are directed at the lesion to destroy the cancer cells. Recovery is pretty easy. My husband has the exact history as yours. A small liver lesion showed up after the induction phase of ipi. We were devastated. He had the procedure and became NED. He was 3c before ipi. He has been 18 months NED without any further immunotherapy . So, I recommend he see an interventional radiologist before he makes any decisions. We know that my husband can seek further immunotherapy if needed and we are thrilled that he hasn't had to undergo any more. Good luck. You can contact me through this website if you want.
-
- August 18, 2015 at 9:04 pm
Hi – ablation is a relatively Minot surgical procedure done by an interventional radiologist. A small incision is made and under X-ray guidance a probe is placed and microwaves are directed at the lesion to destroy the cancer cells. Recovery is pretty easy. My husband has the exact history as yours. A small liver lesion showed up after the induction phase of ipi. We were devastated. He had the procedure and became NED. He was 3c before ipi. He has been 18 months NED without any further immunotherapy . So, I recommend he see an interventional radiologist before he makes any decisions. We know that my husband can seek further immunotherapy if needed and we are thrilled that he hasn't had to undergo any more. Good luck. You can contact me through this website if you want.
-
- August 18, 2015 at 9:04 pm
Hi – ablation is a relatively Minot surgical procedure done by an interventional radiologist. A small incision is made and under X-ray guidance a probe is placed and microwaves are directed at the lesion to destroy the cancer cells. Recovery is pretty easy. My husband has the exact history as yours. A small liver lesion showed up after the induction phase of ipi. We were devastated. He had the procedure and became NED. He was 3c before ipi. He has been 18 months NED without any further immunotherapy . So, I recommend he see an interventional radiologist before he makes any decisions. We know that my husband can seek further immunotherapy if needed and we are thrilled that he hasn't had to undergo any more. Good luck. You can contact me through this website if you want.
-
- August 18, 2015 at 6:25 pm
What I've decided about oncologists is that I want one who is a good odds make. Because it seems that way to me too. Although I had to mix my own judgement in too since I'm the one commiting to it. What I've heard others say here is, try to make the best choice I can based on whatever input I value, then go with that decision and try not to second guess it too much. Which I did in choosing my current treatment.
I've got somethimg like 4 or 5 choices once I'm done with my current trial, which I hope will be due to fullly completing the final planned cycle. I'm not thinking to much about those post-trial choices yet.
-
- August 18, 2015 at 6:25 pm
What I've decided about oncologists is that I want one who is a good odds make. Because it seems that way to me too. Although I had to mix my own judgement in too since I'm the one commiting to it. What I've heard others say here is, try to make the best choice I can based on whatever input I value, then go with that decision and try not to second guess it too much. Which I did in choosing my current treatment.
I've got somethimg like 4 or 5 choices once I'm done with my current trial, which I hope will be due to fullly completing the final planned cycle. I'm not thinking to much about those post-trial choices yet.
-
- August 18, 2015 at 3:56 pm
This is one of the dilemmas. He can start avelumab first, if it doesnt work he can go on opdivo. But he cannot start opdivo then go to avelumab.I just want him to be healthy and to live a long healthy life with his annoying wife π it almost feels like we are gambling. We could go with the doctor at MDAnderson who works in the melanoma department whom we trust and beleive in. He recommends keytruda or opdivo. Or he could go with this new clinical trial that was introduced to us by a clinical trial guru who recommends avelumab. (And if it doesnt work, go to opdivo/keytruda.)
-
- August 18, 2015 at 3:16 pm
Hi Rebekah,
One other thing to consider about a clinical trial vs an approved drug is that if you start with the approved drug (Keytruda or Opdivo) that might disqualify later participation in *some* not all clinical studied involving, perhaps some, immunotherapies. whereas if you start with the study drug, you should be able to fall back on keytruda or opdivo if that were to be necessary.
I am not familiar with avelumab although I almost ended up on a study with a different anti-PDL1 drug combined witj a MEK inhibitor.
Lots to consider… hooe this helps.
-Kyle
-
- You must be logged in to reply to this topic.